Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-01

FDA Approved: SUMATRIPTAN SUCCINATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Sumatriptan Succinate from Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan succinate (Sumatriptan succinate)

Snippet

SUPPL AP for SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)